Arkolith/Insider Trading/AGLE/Form 4

Goldberg Jeff Marc

President and CEO, DirectorAeglea BioTherapeutics, Inc. (AGLE) · full profile →Form 4 · filed Dec 1, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 29, 2022Grant(A)1.9M—$01.9M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-059262) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML